The Short Version
The evidence does not support the assertion that common cosmetic ingredients are toxic at regulatory-approved doses. Regulatory frameworks in the EU, Canada, and (post-MoCRA) the U.S. set approved doses well below observed adverse-effect thresholds, typically with 100x safety margins. Sources cited in support describe associations at unspecified exposure levels, regulatory gaps, or scientific uncertainty about long-term cumulative effects — none demonstrate toxicity at approved doses under normal use. The claim conflates hazard identification with actual risk at regulated exposure levels.